A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation

Background: Voriconazole is one of the first-line therapies for invasive pulmonary aspergillosis. Drug concentrations might be significantly influenced by the use of extracorporeal membrane oxygenation (ECMO). We aimed to assess the effect of ECMO on voriconazole exposure in a large patient populati...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Daele, Ruth, Bekkers, Britt, Lindfors, Mattias, Broman, Lars Mikael, Schauwvlieghe, Alexander, Rijnders, Bart, Hunfeld, Nicole G. M., Juffermans, Nicole P., Taccone, Fabio Silvio, Coimbra Sousa, Carlos Antônio, Jacquet, Luc-Marie, Laterre, Pierre-François, Nulens, Eric, Grootaert, Veerle, Lyster, Haifa, Reed, Anna, Patel, Brijesh, Meersseman, Philippe, Debaveye, Yves, Wauters, Joost, Vandenbriele, Christophe, Spriet, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303158/
https://www.ncbi.nlm.nih.gov/pubmed/34361978
http://dx.doi.org/10.3390/microorganisms9071543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303158/
https://www.ncbi.nlm.nih.gov/pubmed/34361978
http://dx.doi.org/10.3390/microorganisms9071543

Ejemplares similares